Effects of Postponing Treatment in the Second Year of Cladribine Administration: Clinical Trial Simulation Analysis of Absolute Lymphocyte Counts and Relapse Rate in Patients with...

Autor Terranova, Nadia, Hicking, Christine, Dangond, Fernando, Munafo, Alain
Vydáno v Clin Pharmacokinet (2018)

Effects of cladribine tablets on heart rate, atrio‐ventricular conduction and cardiac repolarization in patients with relapsing multiple sclerosis

Autor Hermann, Robert, Litwin, Jeffrey S., Friberg, Lena E., Dangond, Fernando, Munafo, Alain
Vydáno v Br J Clin Pharmacol (2019)

Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study

Autor Rivera, Victor M, Jeffery, Douglas R, Weinstock-Guttman, Bianca, Bock, Daena, Dangond, Fernando
Vydáno 2013

IN VITRO ASSESSMENT OF THE BIOLOGIC ACTIVITY OF INTERFERON BETA FORMULATIONS USED FOR THE TREATMENT OF RELAPSING MULTIPLE SCLEROSIS

Autor Scagnolari, Carolina, Selvaggi, Carla, Di Biase, Emilia, Fraulo, Maurizio, Dangond, Fernando, Antonelli, Guido
Vydáno 2014

Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory a...

Autor Traboulsee, Anthony, Li, David K. B., Cascione, Mark, Fang, Juanzhi, Dangond, Fernando, Miller, Aaron
Vydáno v BMC Neurol (2018)

Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing–remitting...

Autor Traboulsee, Anthony, Li, David K. B., Cascione, Mark, Fang, Juanzhi, Dangond, Fernando, Miller, Aaron
Vydáno v BMC Neurol (2018)

Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter...

Autor Singer, Barry, Bandari, Daniel, Cascione, Mark, LaGanke, Christopher, Huddlestone, John, Bennett, Randy, Dangond, Fernando
Vydáno 2012

Cladribine tablets added to IFN-β in active relapsing MS: The ONWARD study

Autor Montalban, Xavier, Leist, Thomas P., Cohen, Bruce A., Moses, Harold, Campbell, Jackie, Hicking, Christine, Dangond, Fernando
Vydáno v Neurol Neuroimmunol Neuroinflamm (2018)

The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review

Autor Rammohan, Kottil, Coyle, Patricia K., Sylvester, Elke, Galazka, Andrew, Dangond, Fernando, Grosso, Megan, Leist, Thomas P.
Vydáno v Drugs (2020)

Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers

Autor Stuve, Olaf, Soelberg Soerensen, Per, Leist, Thomas, Giovannoni, Gavin, Hyvert, Yann, Damian, Doris, Dangond, Fernando, Boschert, Ursula
Vydáno v Ther Adv Neurol Disord (2019)

Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS

Autor Freedman, Mark S., Brod, Staley, Singer, Barry A., Cohen, Bruce A., Hayward, Brooke, Dangond, Fernando, Coyle, Patricia K.
Vydáno v J Neurol (2019)

Neural Stem/Progenitor Cells Express Costimulatory Molecules That Are Differentially Regulated by Inflammatory and Apoptotic Stimuli

Autor Imitola, Jaime, Comabella, Manuel, Chandraker, Anil K., Dangond, Fernando, Sayegh, Mohamed H., Snyder, Evan Y., Khoury, Samia J.
Vydáno 2004

Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study

Autor Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin
Vydáno v Ther Adv Neurol Disord (2018)

Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety

Autor Giovannoni, Gavin, Galazka, Andrew, Schick, Regina, Leist, Thomas, Comi, Giancarlo, Montalban, Xavier, Damian, Doris, Dangond, Fernando, Cook, Stuart
Vydáno v Drug Saf (2020)

Noninfectious entry of HIV-1 into peripheral and brain macrophages mediated by the mannose receptor

Autor Trujillo, J. Roberto, Rogers, Rick, Molina, Ramon M., Dangond, Fernando, McLane, Mary Fran, Essex, Max, Brain, Joseph D.
Vydáno 2007

Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets

Autor De Stefano, Nicola, Giorgio, Antonio, Battaglini, Marco, De Leucio, Alessandro, Hicking, Christine, Dangond, Fernando, Giovannoni, Gavin, Sormani, Maria Pia
Vydáno v Mult Scler (2017)

Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

Autor Giovannoni, Gavin, Soelberg Sorensen, Per, Cook, Stuart, Rammohan, Kottil W, Rieckmann, Peter, Comi, Giancarlo, Dangond, Fernando, Hicking, Christine, Vermersch, Patrick
Vydáno v Mult Scler (2018)

Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis

Autor Oh, Jiwon, Walker, Bryan, Giovannoni, Gavin, Jack, Dominic, Dangond, Fernando, Nolting, Axel, Aldridge, Julie, Lebson, Lori A, Leist, Thomas P
Vydáno v Mult Scler J Exp Transl Clin (2021)

The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study

Autor Freedman, Mark S, Leist, Thomas P, Comi, Giancarlo, Cree, Bruce AC, Coyle, Patricia K, Hartung, Hans-Peter, Vermersch, Patrick, Damian, Doris, Dangond, Fernando
Vydáno v Mult Scler J Exp Transl Clin (2017)

A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions an...

Autor Zivadinov, Robert, Dwyer, Michael, Markovic-Plese, Silva, Hayward, Brooke, Bergsland, Niels, Heininen-Brown, Mari, Carl, Ellen, Kennedy, Cheryl, Dangond, Fernando, Weinstock-Guttman, Bianca
Vydáno v Ther Adv Neurol Disord (2015)